TY  - GEN
AU  - Maunoury,Franck
AU  - Clément,Aurore
AU  - Nwankwo,Chizoba
AU  - Levy-Bachelot,Laurie
AU  - Abergel,Armand
AU  - Di Martino,Vincent
AU  - Thervet,Eric
AU  - Durand-Zaleski,Isabelle
TI  - Cost-effectiveness analysis of elbasvir-grazoprevir regimen for treating hepatitis C virus genotype 1 infection in stage 4-5 chronic kidney disease patients in France
SN  - 1932-6203
PY  - 2018///0705
KW  - Amides
KW  - Antiviral Agents
KW  - economics
KW  - Benzofurans
KW  - Carbamates
KW  - Cost-Benefit Analysis
KW  - methods
KW  - Cyclopropanes
KW  - Drug Therapy, Combination
KW  - Female
KW  - France
KW  - Genotype
KW  - Hepacivirus
KW  - genetics
KW  - Hepatitis C, Chronic
KW  - complications
KW  - Humans
KW  - Imidazoles
KW  - Kidney Failure, Chronic
KW  - Liver Cirrhosis
KW  - Male
KW  - Middle Aged
KW  - Models, Economic
KW  - Quality-Adjusted Life Years
KW  - Quinoxalines
KW  - RNA, Viral
KW  - Randomized Controlled Trials as Topic
KW  - Renal Dialysis
KW  - Sulfonamides
N1  - Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1371/journal.pone.0194329
ER  -